CAR3: Study Day for Haematology Nurses
Emerging Therapies – let’s focus on CAR-T cell therapy
Surabhi Chaturvedi (MSc, MA)
Surabhi Chaturvedi (MSc, MA) is a psychotherapist and counsellor specialising in Haemato-Oncology at King’s College Hospital, London. She provides psychological interventions to support patients and informal caregivers affected by blood cancers and other disorders of the bone marrow at any point in the patient’s pathway from diagnosis onwards.
She also conducts routine holistic psychological assessments for all patients scheduled to undergo Stem Cell Transplantation or CAR-T treatment at King’s College Hospital.
In addition to her clinical work with outpatients and with inpatients on Haematology wards, Surabhi delivers training and support to medical and nursing colleagues on psychological aspects of caring for blood cancer patients. She has presented talks at several national and international Haematology conferences.
Rose is a Lecturer Practitioner at the Royal Marsden Hospital. She teaches on a variety of cancer care modules and works clinically with haemato-oncology patients. Prior to this role, Rose was a Research Nurse in CAR-T at King’s College Hospital. She is the nurse member of the EBMT Cellular Therapy and Immunobiology Working Party and has presented at a number of national and international conferences on the subject of the nursing care of patients receiving CAR-T therapy.
Dr Kuhnl is the Consultant Haematologist and Lymphoma Clinical Lead at King’s College Hospital, London.
She trained at Charité University Hospital Berlin, Germany, completed her specialist qualification for Haemato-Oncology in 2015 and became an Honorary Senior Lecturer at Berlin University in 2017. She came to the UK through a 2 year Research Fellowship to work in Prof David Grimwade’s lab at the Department of Medical and Molecular Genetics, King’s College London, and later focused on clinical research in high-grade lymphoma under Prof David Cunningham at The Royal Marsden Hospital. Since 2017, Dr Kuhnl has worked as a Consultant Haematologist at King’s College Hospital with a special interest in high-grade lymphoma and CAR-T. Dr Kuhnl has led the UK-wide analysis of real-world outcomes of high-grade lymphoma patients treated with CD19 CAR-T, as recently presented at ASH 2019 and EHA 2020.
Alice is the Lead Pharmacist for Advanced Therapy Medicinal Products (ATMPs) at the Royal Marsden Hospital (RMH) where she works with a range of advanced therapies including CAR-T cells. Her particular area of interest is CAR-T cell toxicity management.
Prior to her role at RMH, she worked at King’s College Hospital as a Specialist Pharmacist in Haematology-Oncology where she was heavily involved in introducing and delivering the first commercial CAR-T programme in the UK.
Maria graduated from the University of Edinburgh in 2013 and has been working as a BMT CNS since June 2016 at the Bristol Haematology and Oncology Centre. In February 2019, the Centre started delivering CAR-T cells and supporting patients through this has become a key part of her role.
Maria spends her spare time with her sausage dog.
Órla is the Lead Nurse for Haematology at King’s College NHS Foundation Trust, London. Having trained in University College Dublin, Ireland she moved to London in 2002 and has been a Haematology Nurse for 20 years. Previously she was the Lead Lymphoid Clinical Nurse Specialist where she developed and ran several nurse-led initiatives including long term follow-up, bone marrows and telephone clinics. She is an active member of the EBMT Nurses Group and runs the EBMT Nurses Group Twitter account. She has extensive experience in CAR-T therapy and has set up and now manages the CAR T service at King’s. She set up and chaired these nurse CAR T meetings in 2017.
Ruth is a Consultant in Palliative Care at King’s College Hospital, London.
Elaine Vickers, BMedSc, PhD
Elaine has a degree in Medical Science from the University of Birmingham and a PhD in Molecular Biology from the University of Manchester. She also has fifteen years of experience in communicating science to a wide range of audiences.
She has worked as a science communicator for three of the UK’s leading medical research charities, including four years in the Science Information team at Cancer Research UK. In 2011 Elaine left London and the charity sector to run Science Communicated Ltd full-time and she is now based in Manchester.
When training, Elaine’s energetic and approachable style ensures that delegates not only gain new knowledge and insight, but also have a hunger to learn more.
Alongside delivering courses, Elaine has written a book ‘A Beginner’s Guide to Targeted Cancer Treatments’, which is an accessible guide to the principles behind new, more targeted drug treatments for cancer. Written for anyone who encounters cancer patients, cancer data or cancer terminology, but has no more than a passing knowledge of cell biology. In September 2019 it was Highly Commended at the British Medical Association medical book awards.